Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-06
2011-11-22
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S546000
Reexamination Certificate
active
08063037
ABSTRACT:
The present invention provides new progesterone receptor modulators which are dibenzo[b,f]pyrido[1,2-d]oxazepine-2-amines or dibenzo[b,f]prido[1,2-d]thiazepine-2-amines, and uses thereof.
REFERENCES:
patent: 3966723 (1976-06-01), van der Burg
patent: 4016161 (1977-04-01), van der Burg
patent: 4054572 (1977-10-01), van der Burg
patent: 5688810 (1997-11-01), Jones et al.
patent: 7737136 (2010-06-01), Hermkens et al.
patent: 2008/0090804 (2008-04-01), Rewinkel
patent: 2 420 168 (1974-04-01), None
patent: 0 303 306 (1989-02-01), None
patent: 0 421 802 (1991-04-01), None
patent: 0 876 815 (1998-11-01), None
patent: WO 03/084963 (2003-10-01), None
patent: WO 2006/084917 (2006-08-01), None
patent: WO 2008/037746 (2008-04-01), None
Caulfield et al., Synthesis of 1-amino-1,2,3,14b-tetrahydro-4H-pyrido[1,2-d]dibenzo[b,f][1,4]oxazepine and Related Compounds, Journal of the Chemical Society, Perkins Transactions 1, No. 6, pp. 545-553, 1996.
Gilman et al., The Pharmacological Basis of Therapeutics, Pergamon Press, 8thEdition, pp. 1397-1401, 1990.
Beato, et al., “DNA Regulatory Elements for Steroid Hormones”, J. Steroid Biochem., vol. 32, No. 5, pp. 737-748 (1989).
Caufield, et al., “Synthesis of 1-amino-1,2,3,14b-tetrahydro-4H-pyrido[1,2-d]-dibenzo[b,f] [1,4]oxazepine and related compounds”, J. Chem. Soc., Perkin Trans. 1, No. 6, pp. 545-553, (1995).
Dijkema, et al., “Human Progesterone Receptor A and B Isoforms in CHO Cells. I. Stable Transfection of Receptor and Receptor-responsive Reporter Genes: Transcription Modulation by (Anti)progestagens”, J. Steroid Biochem. Molec. Biol., vol. 64, No. 3-4, pp. 147-156 (1998).
Schoonen, et al., “Development of a High-Throughput in Vitro Bioassay to Assess Potencies of Progestagenic Compounds Using Chinese Hamster Ovary Cells Stably Transfected with the Human Progesterone Receptor and a Luciferase Reporter System”, Analytical Biochemistry, vol. 261, pp. 222-224 (1998).
PCT International Search Report dated Aug. 6, 2003 for corresponding PCT Application No. PCT/EP03/50085.
PCT International Search Report and Written Opinion, dated Aug. 12, 2008, which was issued during the prosecution of International Application No. PCT/EP2008/003714, which corresponds to the present application.
PCT International Search Report and Written Opinion, dated Dec. 28, 2007, which was issued during the prosecution of International Application No. PCT/EP2007/060225, which corresponds to the present application.
Folmer Brigitte Johanna Bernita
Ibrahim Hemen
Ollero Maria Lourdes
Rewinkel Johannes Bernardus Maria
Coleman Brenda
Fair Janet E.
N. V. Organon
Todaro John C.
LandOfFree
Progesterone receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Progesterone receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progesterone receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4273082